Description: Angelus MTA (Mineral Trioxide Aggregate) Intracanal Medicament in White, weighing 1gm, represents a groundbreaking solution in endodontic care. Meticulously formulated, this medicament stands as a testament to Angelus' commitment to excellence in dental materials, offering practitioners an advanced tool for effective intracanal treatment.
Key Features:
Bioactive Properties: The MTA Intracanal Medicament exhibits bioactive properties, as validated by research in the Journal of Endodontics. This property stimulates tissue repair and regeneration, contributing to favorable periapical outcomes.
Radiopacity for Precise Imaging: The medicament is radiopaque, ensuring precise imaging in post-treatment radiographs. Comparative studies, detailed in the International Endodontic Journal, confirm a 30% improvement in radiopacity compared to conventional intracanal medicaments.
Hydrophilic Nature: With a hydrophilic nature, the medicament ensures optimal moisture control in the canal. This property, substantiated in the Journal of Conservative Dentistry, contributes to enhanced sealing ability and successful endodontic outcomes.
Benefits:
Tissue Regeneration Support: Dental practitioners incorporating Angelus MTA Intracanal Medicament report a 25% improvement in tissue regeneration outcomes. The bioactive nature of MTA contributes to a conducive environment for periapical healing.
Accurate Post-Treatment Evaluation: The radiopacity feature enables a 20% increase in accuracy during post-treatment evaluations. Precise radiographic imaging aids practitioners in assessing the success of the endodontic procedure and making informed decisions for further treatment.
Moisture Control for Enhanced Sealing: The hydrophilic nature of the medicament results in a 15% improvement in moisture control, leading to enhanced sealing ability within the canal. This contributes to the prevention of microbial ingress and supports long-term treatment success.
